Le Lézard
Classified in: Health, Business
Subject: RCN

Joerns Healthcare Completes Reorganization Plans


CHARLOTTE, N.C., Aug. 21, 2019 /PRNewswire/ -- Joerns Healthcare, a leading durable medical equipment manufacturer and supplier, announced today that the financial reorganization for the company and its domestic subsidiaries is complete following the effectiveness and consummation of Joerns' court-approved plan of reorganization.

The reorganization reduced the company's debt by more than $320 million, while providing $40 million in new capital to support Joerns' ongoing operations and continued investments.

"This successful reorganization represents an important milestone in the company's 130 year history of exceptional customer service and unparalleled patient care," said Joerns Senior Vice President and Chief Financial Officer John Regan. "We're extraordinarily well-positioned now to further extend our industry leadership in improving the lives of others, as exemplified by the company's introduction of four new products during the past six months that serve patients across the care continuum."

About Joerns Healthcare
Joerns Healthcare is a leading vertically-integrated manufacturer, distributor, and national service provider of healthcare beds, therapeutic support surfaces, safe patient handling products, and negative pressure wound therapy devices, with a number of industry-leading brands, including Ultracare® XT bed frame and Hoyer® lifts. Joerns helps healthcare providers, across the care continuum, solve complex medical equipment challenges, improve patient and caregiver safety and speed patient healing with its renowned Purple Shirt service. Headquartered in Charlotte, North Carolina with 1,700 employees throughout North America and Europe, Joerns Healthcare is committed to delivering solutions that improve the lives of patients and care providers.

For more information, visit www.Joerns.com.

SOURCE Joerns Healthcare


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: